Publication:
The immune system as a chronotoxicity target of the anticancer mTOR inhibitor everolimus.

Simple item page
dc.contributor.authorOZTURK, N
dc.contributor.authorOzturk, DİLEK
dc.contributor.authorPALA-KARA, Z
dc.contributor.authorKAPTAN, E
dc.contributor.authorSANCAR-BAS, S
dc.contributor.authorOZSOY, N
dc.contributor.authorCINAR, S
dc.contributor.authorDENIZ, G
dc.contributor.authorLI, XM
dc.contributor.authorGIACCHETTI, S
dc.contributor.authorLÉVI, F
dc.contributor.authorOKYAR, A
dc.contributor.institutionauthorÖZTÜRK CİVELEK, DİLEK
dc.date.accessioned2019-10-05T12:51:59Z
dc.date.available2019-10-05T12:51:59Z
dc.date.issued2018-05-01
dc.description.sponsorshipİstanbul Üniversitesi
dc.identifier10.1007/s11096-009-9333-9
dc.identifier.citationOZTURK N., Ozturk D., PALA-KARA Z., KAPTAN E., SANCAR-BAS S., OZSOY N., CINAR S., DENIZ G., LI X., GIACCHETTI S., et al., -The immune system as a chronotoxicity target of the anticancer mTOR inhibitor everolimus.-, Chronobiology international, cilt.35, ss.705-718, 2018
dc.identifier.doi10.1080/07420528.2018.1432632
dc.identifier.pubmed29400578
dc.identifier.scopus85041579344
dc.identifier.urihttps://hdl.handle.net/20.500.12645/769
dc.identifier.wosWOS:000433933300009
dc.titleThe immune system as a chronotoxicity target of the anticancer mTOR inhibitor everolimus.
dc.typeArticle
dspace.entity.typePublication
local.article.journalnamePHARMACY WORLD & SCIENCE
local.avesis.id10c3e21b-e25b-4e69-a55a-447a48ccd1fc
local.avesis.response639
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication821c461c-752b-4a78-a2e5-a6aaf5076b88
relation.isAuthorOfPublication.latestForDiscovery821c461c-752b-4a78-a2e5-a6aaf5076b88

Files

Collections

Yayınlar - Eserler
Eczacılık Fakültesi